New hope for aspirin allergy and nasal polyps: dupilumab under the microscope
NCT ID NCT05575037
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 22 times
Summary
This study looks at how dupilumab helps people with aspirin-exacerbated respiratory disease (AERD) and nasal polyps. Seventeen adults with AERD, asthma, and nasal polyps received the drug to see if it reduces inflammation and improves smell. The goal is to understand how the drug works, not to cure the condition.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NASAL POLYPS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.